An Exploratory Clinical Study of Anti-CD19 CAR NK Cell (KN5501) in the Treatment of Relapsed/Refractory Immune Nephropathy
Clinical trial NCT06469190 · RECRUITING
Trial details
- NCT number
- NCT06469190
- Sponsor
- Changhai Hospital
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-21
- Primary completion
- 2026-06-20
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.